“India is largely dependent on China for API imports. Until recently, China used to sell APIs at lower prices due to their lower labour costs. The profit margin on APIs used to be low, and Indian drug manufacturers thought it wise to import APIs, make formulation drugs and export them,” said Bhaskar.
Read more: Efforts on to rely less on China, Italy for pharma ingredients